F-Star Articles
F-Star and Merck Serono in up to 492 million-euro collaboration on novel targeted biologics
9 September 2011
Boehringer Ingelheim in second antibody deal, this one with f-star worth potential 180-million euros
23 November 2010
Showing 1-2 of 2 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
